Weixin Xu

1.0k citations

17 papers · 656 indexed · h-index 14

Co-authors: Diane Joseph‐McCarthy Laura Seestaller Jeremy I. Levin Janet Sredy Joseph R. Taylor Diane R. Sawicki Michael S. Malamas Donald Sullivan
Topics: Protein Tyrosine Phosphatases (4 papers)Galectins and Cancer Biology (3 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)
Cited by: Toxicology Organic Chemistry Oncology
Journals: Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: United States Canada India

In The Last Decade

Weixin Xu

16 papers receiving 625 citations

Peers

Countries citing papers authored by Weixin Xu

Since Specialization

Citations

This map shows the geographic impact of Weixin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixin Xu more than expected).

Fields of papers citing papers by Weixin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixin Xu. The network helps show where Weixin Xu may publish in the future.

Co-authorship network of co-authors of Weixin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weixin Xu. A scholar is included among the top collaborators of Weixin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixin Xu. Weixin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates 2010 ·Journal of Medicinal Chemistry ·Joseph T. Lundquist,Douglas C. Harnish,(unknown),John F. Mehlmann,Rayomand J. Unwalla,(unknown),Matthew L. Crawley,(unknown),Daniel M. Green,Weixin Xu,Wah-Tung Hum,(unknown),Irene Feingold,(unknown),Mark J. Evans,KehDih Lai,Lisa Borges-Marcucci,Paige E. Mahaney,Jay Wrobel	42
2	3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3 2009 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Wayne E. Childers,(unknown),Arlene Dietrich,Boyd L. Harrison,Vasilios M. Marathias,Gregory J. Tawa,Ann Aulabaugh,Rebecca Cowling,(unknown),Weixin Xu,Lidia Mosyak,F. Moy,Wah-Tung Hum,Andrew Wood,Albert J. Robichaud	18
3	Synthesis and activity of quinolinylmethyl P1′ α-sulfone piperidine hydroxamate inhibitors of TACE 2009 ·Bioorganic & Medicinal Chemistry Letters ·Chunchun Zhang,Frank Lovering,Mark L. Behnke,Arie Zask,Vincent Sandanayaka,Linhong Sun,Yi Zhun Zhu,Weixin Xu,Yuhua Zhang,Jeremy I. Levin	8
4	Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-α converting enzyme (TACE) inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·Kaapjoo Park,Ariamala Gopalsamy,(unknown),John W. Ellingboe,Weixin Xu,Yuhua Zhang,Jeremy I. Levin	24
5	Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Dan M. Berger,(unknown),Minu Dutia,Dennis Powell,(unknown),Ariamala Gopalsamy,Jeremy I. Levin,Kyung‐Hee Kim,Weixin Xu,James E. Wilhelm,Yongbo Hu,Karen Collins,Larry Feldberg,(unknown),(unknown),Donald Wojciechowicz,Robert Mallon	32
6	Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment 2008 ·Bioorganic & Medicinal Chemistry Letters ·Scott C. Mayer,(unknown),Frank Boschelli,Li Di,Mark R. Johnson,Cynthia Hess Kenny,Girija Krishnamurthy,Kristina M. K. Kutterer,F. Moy,Susan Petusky,Malini Ravi,Diane Tkach,Hwei‐Ru Tsou,Weixin Xu	60
7	Structure‐Based Optimization of Protein Tyrosine Phosphatase‐1 B Inhibitors: Capturing Interactions with Arginine 24 2008 ·ChemMedChem ·Zhao‐Kui Wan,Jinbo Lee,Rajeev Hotchandani,Alessandro Moretto,Eva Binnun,Douglas Wilson,(unknown),Bruce Follows,Manus Ipek,Weixin Xu,Diane Joseph‐McCarthy,(unknown),May Tam,David V. Erbe,James F. Tobin,(unknown),S. Y. K. TAM,Tarek S. Mansour,Junjun Wu	14
8	Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Scott C. Mayer,Dan M. Berger,Diane H. Boschelli,Frank Boschelli,Li Di,Xuemei Du,Minu Dutia,(unknown),Mark Johnson,Cynthia Hess Kenny,Girija Krishnamurthy,F. Moy,Susan Petusky,Diane Tkach,(unknown),Biqi Wu,Weixin Xu	34
9	Structure-based design of TACE selective inhibitors: Manipulations in the S1′–S3′ pocket 2007 ·Bioorganic & Medicinal Chemistry ·Adrian Huang,Diane Joseph‐McCarthy,Frank Lovering,Linhong Sun,Weiheng Wang,Weixin Xu,Yi Zhun Zhu,Junqing Cui,Yuhua Zhang,Jeremy I. Levin	24
10	Probing acid replacements of thiophene PTP1B inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhao‐Kui Wan,Bruce Follows,(unknown),Douglas Wilson,Eva Binnun,Weixin Xu,Diane Joseph‐McCarthy,Junjun Wu,Michael J. Smith,Yanling Zhang,May Tam,David V. Erbe,Steve Tam,Eddine Saiah,Jinbo Lee	35
11	Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: Capturing interactions with Asp48 2006 ·Bioorganic & Medicinal Chemistry Letters ·Zhao‐Kui Wan,Jinbo Lee,Weixin Xu,David V. Erbe,Diane Joseph‐McCarthy,Bruce Follows,Yanling Zhang	49
12	Identification of potent and selective TACE inhibitors via the S1 pocket 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Diane Joseph‐McCarthy,Jeremy I. Levin,Henry‐Georges Lombart,Frank Lovering,Linhong Sun,Weiheng Wang,Weixin Xu,Yuhua Zhang	34
13	Characterization of (2R, 3S)-2-({[4-(2-butynyloxy)phenyl]sulfonyl}amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-α converting enzyme 2004 ·International Immunopharmacology ·Yuhua Zhang,Martin Hegen,Jun Xu,James C. Keith,Guixian Jin,Xuemei Du,Terri Cummons,Barbara J. Sheppard,Linhong Sun,(unknown),Vikram Rao,Qin Wang,Weixin Xu,Rebecca Cowling,Cheryl Nickerson‐Nutter,Jay Gibbons,J.S. Skotnicki,Lih‐Ling Lin,Jeremy I. Levin	48
14	Synthesis and Structure−Activity Relationships of 4-alkynyloxy Phenyl Sulfanyl, Sulfinyl, and Sulfonyl Alkyl Hydroxamates as Tumor Necrosis Factor-α Converting Enzyme and Matrix Metalloproteinase Inhibitors 2004 ·Journal of Medicinal Chemistry ·Aranapakam M. Venkatesan,(unknown),G Grosu,(unknown),Arie Zask,Jeremy I. Levin,John W. Ellingboe,Jerauld S. Skotnicki,John F. DiJoseph,Amy Sung,Guixian Jin,Weixin Xu,Diane Joseph‐McCarthy,D. Barone	35
15	Novel Benzofuran and Benzothiophene Biphenyls as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties 2000 ·Journal of Medicinal Chemistry ·Michael S. Malamas,Janet Sredy,Christopher Moxham,Alan H. Katz,Weixin Xu,Robert McDevitt,(unknown),Diane R. Sawicki,Laura Seestaller,Donald Sullivan,Joseph R. Taylor	188
16	The Activation of C-H Bond Catalyzed by Organotransition-Metal Complexes Containing Diphosphine Chelate Ligand 1987 ·Phosphorous and Sulfur and the Related Elements ·(unknown),Liangfu Zhang,(unknown),Qiongzhong Jiang,(unknown),Weixin Xu	0
17	Coordination chemistry of alkali and alkaline earth cations: Synthesis and crystal structure of potassium(benzo-15-crown-5)2 [3,5-dinitrobenzoate(3,5-dinitrobenzoic acid)2] 1985 ·Journal of Inclusion Phenomena and Macrocyclic Chemistry ·Weixin Xu,(unknown),Marvin L. Hackert,N. S. Poonia	11

About Weixin Xu

Weixin Xu is a scholar working on Toxicology, Oncology and Organic Chemistry, having authored 17 papers that have together received 656 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (4 papers), Galectins and Cancer Biology (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Toxicology (62 citations), Organic Chemistry (241 citations) and Oncology (170 citations). Weixin Xu has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Diane Joseph‐McCarthy, Laura Seestaller, Jeremy I. Levin, Janet Sredy, Joseph R. Taylor, Diane R. Sawicki, Michael S. Malamas, Donald Sullivan, Christopher Moxham and Alan H. Katz. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact